SARS-CoV-2
MAVERICK™
SARS-CoV-2 Multi-Antigen Serology Panel V2
Is designed to test for SARS-CoV-2 antibodies as well as other viruses that have similar symptoms but are not COVID-19. Unlike competitive serology tests that only detect antibodies to a limited number of SARS-CoV-2 antigens, the Maverick ™ SARS-CoV-2 Multi-Antigen Serology Panel v2 includes five SARS-CoV-2 antigens and eight other virus antigens. The larger number of antigens tested reduces false positives and negatives.
Genalyte outperforms competitors
NorthShore Health System Study: Genalyte is highest performing tests across all competitors
Antibody Test
Samples
197
197
197
197
accuracy
99%
98%
96%
93%
sensitivity
98%
96%
92%
87%
specificity
100%
100%
100%
100%
SARS-CoV-2 Panel Analytes
SARS-COV-2
- Anti-CoV-2 Nucleocapsid
- Anti-CoV-2 Spike S1 RBD
- Anti-CoV-2 Spike S152
- Anti-CoV-2 Spike S2
- Anti-CoV-2 Spike S1
INFLUENZA
- Anti-Influenza H1
- Anti-Influenza H3
Benign Coronavirus
- Anti-CoV HKU1 Spike
- Anti-CoV OC43 Spike
- Anti-CoV NL63 Nucleoprotein
- Anti-CoV 229E Spike
MERS
Anti-MERS Spike S1
SARS-COV-1
Anti-CoV-1 Nucleocapsid
Assay Specifications
Antibodies Detected
IgM & IgG
Sensitivity
96.1%
Number of Targets
26
Specificity
97.7%
Time to Result
20 Min
Sample Type